is tirzepatide a glp-1 agonist Tirzepatide, dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Tirzepatide 10mg — GLP-1/GIP Dual-Agonist

The rapidly turning tide in Mojsovs recognition has necessitated significant revisions to the manuscript

I put a lot of weight on as an adult when I had my five children, and because of my health issues

If you are not losing fat, protecting your muscle, and building habits that outlast the medication, you are only getting half the picture

This suggests that reduced responsiveness to GLP-1 RA therapy may, at least in part, reflect a more advanced or entrenched dysbiotic state rather than a direct failure of incretin signalingThis framework places microbiota-related factors within a hierarchical network of host, environmental, and pharmacological determinants, emphasizing their role as modifiers rather than primary drivers of therapeutic variability